Literature DB >> 12706492

Multiple roles of oxidants in the pathogenesis of asbestos-induced diseases.

Arti Shukla1, Mary Gulumian, Tom K Hei, David Kamp, Qamar Rahman, Brooke T Mossman.   

Abstract

Exposure to asbestos causes cellular damage, leading to asbestosis, bronchogenic carcinoma, and mesothelioma in humans. The pathogenesis of asbestos-related diseases is complicated and still poorly understood. Studies on animal models and cell cultures have indicated that asbestos fibers generate reactive oxygen and nitrogen species (ROS/RNS) and cause oxidation and/or nitrosylation of proteins and DNA. The ionic state of iron and its ability to be mobilized determine the oxidant-inducing potential of pathogenic iron-containing asbestos types. In addition to their capacity to damage macromolecules, oxidants play important roles in the initiation of numerous signal transduction pathways that are linked to apoptosis, inflammation, and proliferation. There is strong evidence supporting the premise that oxidants contribute to asbestos-induced lung injury; thus, strategies for reducing oxidant stress to pulmonary cells may attenuate the deleterious effects of asbestos.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706492     DOI: 10.1016/s0891-5849(03)00060-1

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  74 in total

1.  Heme oxygenase-1 promoter polymorphism is associated with risk of malignant mesothelioma.

Authors:  Aki Murakami; Yoshihiro Fujimori; Yoshie Yoshikawa; Shusai Yamada; Kunihiro Tamura; Noriko Hirayama; Takayuki Terada; Kozo Kuribayashi; Chiharu Tabata; Kazuya Fukuoka; Tomoko Tamaoki; Takashi Nakano
Journal:  Lung       Date:  2012-01-21       Impact factor: 2.584

Review 2.  Cellular and molecular parameters of mesothelioma.

Authors:  Maria E Ramos-Nino; Joseph R Testa; Deborah A Altomare; Harvey I Pass; Michele Carbone; Maurizio Bocchetta; Brooke T Mossman
Journal:  J Cell Biochem       Date:  2006-07-01       Impact factor: 4.429

3.  Assessment of the pathogenic potential of asbestiform vs. nonasbestiform particulates (cleavage fragments) in in vitro (cell or organ culture) models and bioassays.

Authors:  Brooke T Mossman
Journal:  Regul Toxicol Pharmacol       Date:  2007-10-11       Impact factor: 3.271

4.  Long-term effects of carbon containing engineered nanomaterials and asbestos in the lung: one year postexposure comparisons.

Authors:  Anna A Shvedova; Naveena Yanamala; Elena R Kisin; Alexey V Tkach; Ashley R Murray; Ann Hubbs; Madalina M Chirila; Phouthone Keohavong; Lyudmila P Sycheva; Valerian E Kagan; Vincent Castranova
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-08       Impact factor: 5.464

5.  Fanconi anemia proteins and endogenous stresses.

Authors:  Qishen Pang; Paul R Andreassen
Journal:  Mutat Res       Date:  2009-07-31       Impact factor: 2.433

6.  Genotoxicity of carbon nanofibers: are they potentially more or less dangerous than carbon nanotubes or asbestos?

Authors:  E R Kisin; A R Murray; L Sargent; D Lowry; M Chirila; K J Siegrist; D Schwegler-Berry; S Leonard; V Castranova; B Fadeel; V E Kagan; A A Shvedova
Journal:  Toxicol Appl Pharmacol       Date:  2011-02-17       Impact factor: 4.219

Review 7.  Extracellular superoxide dismutase in pulmonary fibrosis.

Authors:  Fei Gao; Vuokko L Kinnula; Marjukka Myllärniemi; Tim D Oury
Journal:  Antioxid Redox Signal       Date:  2008-02       Impact factor: 8.401

8.  Immunological changes in mesothelioma patients and their experimental detection.

Authors:  Megumi Maeda; Yoshie Miura; Yasumitsu Nishimura; Shuko Murakami; Hiroaki Hayashi; Naoko Kumagai; Tamayo Hatayama; Minako Katoh; Naomi Miyahara; Shoko Yamamoto; Kazuya Fukuoka; Takumi Kishimoto; Takashi Nakano; Takemi Otsuki
Journal:  Clin Med Circ Respirat Pulm Med       Date:  2008-03-26

9.  Mesothelioma: Do asbestos and carbon nanotubes pose the same health risk?

Authors:  Marie-Claude F Jaurand; Annie Renier; Julien Daubriac
Journal:  Part Fibre Toxicol       Date:  2009-06-12       Impact factor: 9.400

10.  Mechanisms of FUS1/TUSC2 deficiency in mesothelioma and its tumorigenic transcriptional effects.

Authors:  Alla V Ivanova; Sergey V Ivanov; Ljudmila Prudkin; Daisuke Nonaka; Zhandong Liu; Anne Tsao; Ignacio Wistuba; Jack Roth; Harvey I Pass
Journal:  Mol Cancer       Date:  2009-10-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.